国药现代(600420.SH)：国药容生维生素B6注射液增加规格并通过一致性评价

Core Viewpoint - China National Pharmaceutical Group Modern (国药现代) announced that its wholly-owned subsidiary, China National Pharmaceutical Group Rongsheng Pharmaceutical Co., Ltd. (国药容生), received approval from the National Medical Products Administration for a supplemental application regarding Vitamin B6 injection, allowing for an increase in specifications and passing the consistency evaluation for generic drug quality and efficacy [1] Group 1 - The approval of the Vitamin B6 injection's new specifications and the successful consistency evaluation will facilitate future market expansion and sales for the product [1] - The recent developments are not expected to have a significant impact on the company's current operating performance [1]